Long-term-opioid-free Anesthesia in Anterior Cervical Surgery

Sponsor
West China Hospital (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05548465
Collaborator
(none)
100
1
2
15.3
6.5

Study Details

Study Description

Brief Summary

We design this randomized controlled trial to explore the safety and efficacy of the long-term-opioid-free anesthesia in anterior cervical surgery, to reduce the dosage of perioperative long-acting opioids and promoting patients'rehabilitation.

Condition or Disease Intervention/Treatment Phase
  • Drug: Remifentanil Hydrochloride
  • Drug: Sufentanil Citrate
Phase 4

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Safety and Efficacy of Long-term-opioid-free Anesthesia in Anterior Cervical Surgery: a Prospective Randomized Controlled Trial
Anticipated Study Start Date :
Sep 20, 2022
Anticipated Primary Completion Date :
Oct 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Long-term-opioid-free anesthesia group.

Drug: Remifentanil Hydrochloride
Subjects will receive remifentanil anesthesia for operative analgesia.

Active Comparator: Long-term-opioid anesthesia group.

Drug: Sufentanil Citrate
Subjects will receive sufentanil and remifentanil anesthesia for operative analgesia.

Outcome Measures

Primary Outcome Measures

  1. Postoperative numerical rating scales (NRS) at rest. [Up to 48 hours after operation.]

    Resting NRS pain scores at 30 min, 2 h, 6 h, 24 h, 48 h after surgery.

Secondary Outcome Measures

  1. Incidence of post operative nausea and vomiting (PONV). [Up to 30 days after operation.]

    The proportion of subjects who experienced PONV.

  2. Postoperative NRS on movement. [Up to 48 hours after operation.]

    Postoperative NRS pain score on movement, up to 48hr.

  3. Postoperative complications. [Up to 30 days after operation.]

    Incidence of postoperative adverse reactions and complications.

  4. Incidence of intraoperative adverse events. [Intraoperative .]

  5. Postoperative recovery of cervical spine function [Up to 48 hours after operation.]

    Japanese Orthopaedic Association Scores.(JOA scores).

  6. Analgesic medication use before discharge。 [Up to 48 hours after operation.]

  7. Length of stay (LOS) in hospital [Up to 30 days after operation.]

    Time frame from the day of hospital admission to discharge from the hospital (unit: days).

  8. Postoperative LOS [Up to 30 days after operation.]

    Time frame from the day of operation to discharge from the hospital (unit: days).

  9. Total in-hospital cost. [Up to 30 days after operation.]

    Total hospitalization expenses after the destruction of costly consumables in orthopedic operation.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients undergoing anterior cervical surgery., sign the "informed consent form"

  • Age above 18 years old

  • ASA Ⅰ-Ⅲ.

Exclusion Criteria:
  • Pregnant or lactating women.

  • Patients with history of drug abuse, including but not limited to opioids, amphetamines, ketamine, etc

  • Allergic to the materials or drugs used in this study.

  • Patients with current/previous gastrointestinal bleeding and gastric ulcers;

  • Have history of nervous system diseases such as peripheral neuropathy, or psychiatric mental illness.

  • Other conditions that the investigators consider unsuitable for participation in the study, such as deaf, Parkinson's disease, and difficult to communication etc.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Anesthesiology, West China Hospital, Sichuan University Chengdu Sichuan China 610041

Sponsors and Collaborators

  • West China Hospital

Investigators

  • Principal Investigator: Ren Liao, M.D, West China Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ren Liao, professor, West China Hospital
ClinicalTrials.gov Identifier:
NCT05548465
Other Study ID Numbers:
  • WCH20220916
First Posted:
Sep 21, 2022
Last Update Posted:
Sep 21, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 21, 2022